Evaluate lesion in the pancreas. History of necrotizing pancreatitis with necrosectomy in 2012. Evaluate with secretin stimulation. EUS 11/11/2015: 1.2 cm ill-defined hypoechoic focus in pancreatic body with biopsy found to be atypical mucinous epithelial cells, neoplasm not excluded. ABDOMEN:LIVER, BILIARY TRACT: No significant abnormality noted.SPLEEN: No significant abnormality noted.PANCREAS: The intrinsic T1 signal of the pancreas is decreased. There is mild beading and dilatation of the mid to distal pancreatic duct with multiple focal outpouchings, compatible with side branch ectasia, similar to prior CT December 9, 2012. No abnormal corresponding enhancement is identified. No peripancreatic fluid is identified. Post secretin administration, there is compromised compliance of the pancreatic duct. Fluid is seen at the level of the third perforation of the duodenum, confirming satisfactory exocrine function.ADRENAL GLANDS: No significant abnormality noted.KIDNEYS, URETERS: There is a left midpole 1.4 cm simple cyst. No pancreatic mass identified. There is no hydronephrosis.RETROPERITONEUM, LYMPH NODES: No significant abnormality noted.BOWEL, MESENTERY: The bowel loops are normal in appearance. There is no evidence of bowel obstruction. No ascites is identified.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
Mid to distal pancreatic duct dilatation and side branch ectasia, with no enhancing lesion identified. Compromised compliance of the pancreatic duct post secretin administration. Constellation of findings compatible with history of chronic pancreatitis. 